International Commercial Expansion of Amarin’s Products
Outside the United States, geographies currently prioritized by Amarin for commercialization, directly or through commercial partners, include Canada, China, Europe and the Middle East. After further advancement in these geographies in particular, after market access is advanced in Europe, Amarin will be assessing whether to pursue direct sales or partnership opportunities for VASCEPA® (icosapent ethyl) in other parts of the world. Our preference is for partners possessing a presence in multiple markets.
Below are examples of current partnerships that support our global strategy:
China, Hong Kong, Taiwan
Licensed to Edding
Licensed to HLS Therapeutics
Middle East and North Africa
Distributed with Biologix